This inventor holds 1 USPTO granted patent. Top assignee: Lanova Medicines Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Haijuan Gu: Innovator in Bispecific Antibodies
Introduction
Haijuan Gu is a prominent inventor known for her contributions to the field of biomedicine. She has made significant strides in the development of innovative therapies, particularly in the area of bispecific antibodies.
Latest Patents
Haijuan Gu holds a patent for "Bispecific Antibodies Targeting PD1 and VEGF." This invention represents a crucial advancement in cancer treatment, aiming to enhance the efficacy of immunotherapy.
Career Highlights
Currently, Haijuan Gu is associated with Lanova Medicines Limited, where she continues to push the boundaries of medical research. Her work focuses on developing novel therapeutic strategies that can improve patient outcomes.
Collaborations
Throughout her career, Haijuan has collaborated with notable colleagues, including Runsheng Li and Wei Cao. These partnerships have fostered a dynamic research environment that encourages innovation and discovery.
Conclusion
Haijuan Gu's contributions to the field of bispecific antibodies exemplify her dedication to advancing medical science. Her work not only highlights her innovative spirit but also underscores the importance of collaboration in achieving groundbreaking results.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile